• +886-3-5797779 Fax.105





The performance of the Vstrip COVID-19 Antigen Rapid Test for Detection of SARS-CoV-2 was established with 59 individual symptomatic patients who were suspected of COVID-19. Test results were compared to FDA Emergency Use Authorized molecular (RT-PCR) test for detection of SARS-CoV-2. The overall sensitivity and specificity is 83.3% and 98.1%.

The limit of detection (LoD) of this Vstrip® is 1.57×103 TCID50/ml for the CGMH virus strain (conducted at Chang Gung Memorial Hospital, Linkou, Taiwan). The cross-reactivity of this Vstrip® was evaluated with 10 bacteria (at a concentration of over 108 CFU/ml) and 12 viruses (at a concentration of over 104 TCID50 /ml) 1, and none of the microorganisms tested gave a positive result.

 用途: 以抗體庫,針對目標抗原開發專一性抗體。

 收費標準: 額外詳談。

 用途: 抗體庫,針對目標抗原開發專一性抗體,並使用高通量平台進行抗體功能性測試。

 收費標準: 額外詳談。

 用途: 針對細胞表面抗原進行抗體開發,包括雙特異性抗體或抗體藥物偶聯物。

 收費標準: 額外詳談。

 用途: 針對抗原之結構、生化特性或特殊需求,客製化抗體庫可變區域胺基酸變化位置與種類組合並針對目標抗原進行抗體開發。

 收費標準: 額外詳談。

For further inquiries and questions, please contact us by E-mail or phone: +886-3-5797779 Fax:118